Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05965492Phase 3Withdrawn
Phase 3, randomised, open-label trial (2 arms), sponsored by University of Miami. Primary endpoints: Adherence measured by the self-report medication nonadherence scale at 7 days, Satisfaction measured by Satisfaction Likert Scale at 7 days and 1 more. Planned start Jun 2024; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05965492.